• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Palliative care and end-stage liver disease.

作者信息

Walling Anne M, Wenger Neil S

机构信息

Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, California; Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California; RAND Health, Santa Monica, California.

Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles, California; UCLA Health Ethics Center, Los Angeles, California; RAND Health, Santa Monica, California.

出版信息

Clin Gastroenterol Hepatol. 2014 Apr;12(4):699-700. doi: 10.1016/j.cgh.2013.11.010. Epub 2013 Nov 15.

DOI:10.1016/j.cgh.2013.11.010
PMID:24246765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3997050/
Abstract
摘要

相似文献

1
Palliative care and end-stage liver disease.姑息治疗与终末期肝病
Clin Gastroenterol Hepatol. 2014 Apr;12(4):699-700. doi: 10.1016/j.cgh.2013.11.010. Epub 2013 Nov 15.
2
Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management.肝硬化且未进行肝移植的患者很少能获得充分的姑息治疗或适当的管理。
Clin Gastroenterol Hepatol. 2014 Apr;12(4):692-8. doi: 10.1016/j.cgh.2013.08.027. Epub 2013 Aug 24.
3
Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.平衡质量与数量：姑息治疗在失代偿期肝硬化管理中的作用。
Hepatology. 2016 Oct;64(4):1014-6. doi: 10.1002/hep.28717. Epub 2016 Aug 5.
4
The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review.被拒绝肝移植的肝硬化患者姑息治疗服务的利用情况：单中心回顾性研究
Ann Hepatol. 2017 May-Jun;16(3):395-401. doi: 10.5604/16652681.1235482.
5
Palliative care in end-stage liver disease: Time to do better?终末期肝病的姑息治疗：是否该做得更好？
Liver Transpl. 2018 Jul;24(7):961-968. doi: 10.1002/lt.25193.
6
Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.终末期肝病患者的症状患病率和生活质量：系统评价和荟萃分析。
Palliat Med. 2019 Jan;33(1):24-36. doi: 10.1177/0269216318807051. Epub 2018 Oct 22.
7
Palliative care in patients with liver cirrhosis: it is the time to deal with the burden.肝硬化患者的姑息治疗：是时候应对负担了。
BMJ Support Palliat Care. 2015 Dec;5(5):466-7. doi: 10.1136/bmjspcare-2015-000923. Epub 2015 Jun 28.
8
Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals.肝硬化患者的支持性和姑息治疗：患者、家属和卫生专业人员视角的国际系统评价。
J Hepatol. 2018 Dec;69(6):1260-1273. doi: 10.1016/j.jhep.2018.08.028. Epub 2018 Sep 20.
9
Palliative care in decompensated cirrhosis: A review.失代偿期肝硬化的姑息治疗：综述。
Liver Int. 2018 May;38(5):768-775. doi: 10.1111/liv.13620. Epub 2018 Jan 15.
10
Identifying palliative care needs in a Portuguese liver unit.识别葡萄牙肝脏病房的姑息治疗需求。
Liver Int. 2018 Nov;38(11):1982-1987. doi: 10.1111/liv.13865. Epub 2018 May 14.

引用本文的文献

1
Evaluating Performance of the Surprise Question to Predict 12-Month Mortality in Patients With End-Stage Liver Disease.评估意外问题对预测终末期肝病患者12个月死亡率的性能。
Am J Hosp Palliat Care. 2025 Feb 14;42(11):10499091251320057. doi: 10.1177/10499091251320057.
2
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.美国癌症免疫治疗学会（SITC）肝癌治疗免疫治疗临床实践指南。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002794.
3
Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach.制定晚期肝病姑息治疗研究的优先事项：一种多学科方法。
Hepatol Commun. 2021 Sep;5(9):1469-1480. doi: 10.1002/hep4.1743. Epub 2021 Jun 16.
4
Integrated Model for Patient-Centered Advanced Liver Disease Care.以患者为中心的先进肝脏疾病护理综合模式。
Clin Gastroenterol Hepatol. 2020 May;18(5):1015-1024. doi: 10.1016/j.cgh.2019.07.043. Epub 2019 Jul 26.
5
Palliative care for patients with end-stage liver disease: The role of the liver team.终末期肝病患者的姑息治疗：肝病团队的作用。
Clin Liver Dis (Hoboken). 2015 Jul 28;6(1):22-23. doi: 10.1002/cld.474. eCollection 2015 Jul.
6
How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences.基层医疗如何加强肝病患者的临终关怀？对全科医生认知与经验的定性研究。
BMJ Open. 2017 Sep 1;7(8):e017106. doi: 10.1136/bmjopen-2017-017106.
7
Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life.终末期肝病患者生命终末期的姑息治疗和医疗保健利用。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1612-1619.e4. doi: 10.1016/j.cgh.2017.01.030. Epub 2017 Feb 4.
8
Health related management plans improve sleep disorders of patients with chronic liver disease.与健康相关的管理计划可改善慢性肝病患者的睡眠障碍。
Int J Clin Exp Med. 2015 Jun 15;8(6):9883-9. eCollection 2015.
9
Palliative care for patients with end-stage liver disease.终末期肝病患者的姑息治疗。
Curr Gastroenterol Rep. 2015 May;17(5):440. doi: 10.1007/s11894-015-0440-6.
10
Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.2002年至2010年期间美国肝硬化住院患者死亡率的下降情况。
Gastroenterology. 2015 May;148(5):967-977.e2. doi: 10.1053/j.gastro.2015.01.032. Epub 2015 Jan 23.

本文引用的文献

1
Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization.考虑移植对终末期住院患者临终关怀的影响。
Transplantation. 2013 Feb 27;95(4):641-6. doi: 10.1097/TP.0b013e318277f238.
2
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.肝硬化和肝性脑病给患者和照护者带来的多维负担。
Am J Gastroenterol. 2011 Sep;106(9):1646-53. doi: 10.1038/ajg.2011.157. Epub 2011 May 10.
3
Patients on the waiting list for liver transplantation: caregiver burden and stress.等待肝移植的患者：照顾者负担和压力。
Liver Transpl. 2010 Oct;16(10):1164-8. doi: 10.1002/lt.22130.
4
Early palliative care for patients with metastatic non-small-cell lung cancer.转移性非小细胞肺癌患者的早期姑息治疗。
N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678.
5
The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.终末期肝病模型评分的效用：肝移植候选资格的可靠指南，以及为特定患者同时进行临终关怀转诊的依据。
Liver Transpl. 2008 Aug;14(8):1100-6. doi: 10.1002/lt.21398.
6
Promoting declines in the prevalence of late-life disability: comparisons of three potentially high-impact interventions.促进晚年残疾患病率下降：三种潜在高影响力干预措施的比较。
Milbank Q. 2006;84(3):493-520. doi: 10.1111/j.1468-0009.2006.00456.x.
7
Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life".为肝移植候选者整合姑息治疗：“移植状态过好，生存状态过差” 。
JAMA. 2006 May 10;295(18):2168-76. doi: 10.1001/jama.295.18.2168.
8
Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.终末期肝硬化肝病患者的临终情况：来自“理解预后及对治疗结果和风险的偏好研究（SUPPORT）”的见解
J Am Geriatr Soc. 2000 May;48(S1):S122-30.